These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 22553931

  • 1. Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial.
    Monti LD, Setola E, Lucotti PC, Marrocco-Trischitta MM, Comola M, Galluccio E, Poggi A, Mammì S, Catapano AL, Comi G, Chiesa R, Bosi E, Piatti PM.
    Diabetes Obes Metab; 2012 Oct; 14(10):893-900. PubMed ID: 22553931
    [Abstract] [Full Text] [Related]

  • 2. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC, Schwartz S, Rosenberg MA, Jariwala N, Becker RH, Johnston PS.
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [Abstract] [Full Text] [Related]

  • 3. Sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities--the BEGAMI study.
    Hage C, Brismar K, Efendic S, Lundman P, Rydén L, Mellbin L.
    J Intern Med; 2013 Apr; 273(4):410-21. PubMed ID: 23331339
    [Abstract] [Full Text] [Related]

  • 4. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
    Eriksson JG, Lehtovirta M, Ehrnström B, Salmela S, Groop L.
    J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
    [Abstract] [Full Text] [Related]

  • 5. Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.
    Lucotti P, Monti L, Setola E, La Canna G, Castiglioni A, Rossodivita A, Pala MG, Formica F, Paolini G, Catapano AL, Bosi E, Alfieri O, Piatti P.
    Metabolism; 2009 Sep; 58(9):1270-6. PubMed ID: 19592054
    [Abstract] [Full Text] [Related]

  • 6. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y, Lu JM, Sun JF, Li CL, Wang XL, Zhang XQ, Lü ZH, Dou JT, Mu YM.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 17; 89(10):669-72. PubMed ID: 19595059
    [Abstract] [Full Text] [Related]

  • 7. Decreased diabetes risk over 9 year after 18-month oral L-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of L-arginine study).
    Monti LD, Galluccio E, Villa V, Fontana B, Spadoni S, Piatti PM.
    Eur J Nutr; 2018 Dec 17; 57(8):2805-2817. PubMed ID: 29052766
    [Abstract] [Full Text] [Related]

  • 8. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance.
    Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, Kitawaki J, Imai S, Nakano K, Ohta M, Adachi T, Obayashi H, Yoshikawa T.
    Nutr Res; 2008 Mar 17; 28(3):137-43. PubMed ID: 19083400
    [Abstract] [Full Text] [Related]

  • 9. Pharmacogenetic influence of eNOS gene variant on endothelial and glucose metabolism responses to L-arginine supplementation: Post hoc analysis of the L-arginine trial.
    Monti LD, Galluccio E, Fontana B, Spadoni S, Comola M, Marrocco Trischitta MM, Chiesa R, Comi G, Bosi E, Piatti P.
    Metabolism; 2015 Nov 17; 64(11):1582-91. PubMed ID: 26385052
    [Abstract] [Full Text] [Related]

  • 10. Impaired glucose tolerance is not associated with lipid intolerance.
    Henkel E, Temelkova-Kurktschiev T, Koehler C, Pietzsch J, Leonhardt W, Hanefeld M.
    Diabetes Nutr Metab; 2002 Apr 17; 15(2):84-90. PubMed ID: 12059096
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial.
    Lian F, Li G, Chen X, Wang X, Piao C, Wang J, Hong Y, Ba Z, Wu S, Zhou X, Lang J, Liu Y, Zhang R, Hao J, Zhu Z, Li H, Fang Liu H, Cao A, Yan Z, An Y, Bai Y, Wang Q, Zhen Z, Yu C, Wang CZ, Yuan CS, Tong X.
    J Clin Endocrinol Metab; 2014 Feb 17; 99(2):648-55. PubMed ID: 24432995
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients.
    Lucotti P, Setola E, Monti LD, Galluccio E, Costa S, Sandoli EP, Fermo I, Rabaiotti G, Gatti R, Piatti P.
    Am J Physiol Endocrinol Metab; 2006 Nov 17; 291(5):E906-12. PubMed ID: 16772327
    [Abstract] [Full Text] [Related]

  • 14. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
    Bao YQ, Jia WP, Zhu M, Lu JX, Chen L, Xiang KS.
    Zhonghua Yi Xue Za Zhi; 2004 Nov 02; 84(21):1781-4. PubMed ID: 15631773
    [Abstract] [Full Text] [Related]

  • 15. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome--the Chennai Urban Rural Epidemiology Study.
    Gokulakrishnan K, Deepa R, Mohan V, Gross MD.
    Metabolism; 2006 Feb 02; 55(2):237-42. PubMed ID: 16423632
    [Abstract] [Full Text] [Related]

  • 16. Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.
    Bianchi C, Miccoli R, Bonadonna RC, Giorgino F, Frontoni S, Faloia E, Marchesini G, Dolci MA, Alviggi L, Gnasso A, Consoli A, Cavalot F, Cavallo MG, Leonetti F, Giaccari A, Del Prato S, GENFIEV Investigators.
    Nutr Metab Cardiovasc Dis; 2011 Sep 02; 21(9):699-705. PubMed ID: 21291660
    [Abstract] [Full Text] [Related]

  • 17. Beneficial role of L-arginine in cardiac matrix remodelling in insulin resistant rats.
    Monti LD, Galluccio E, Lucotti P, Setola E, Costa S, Fontana B, Oldani M, Merante D, Di Blasi P, Bosi E, Piatti PM.
    Eur J Clin Invest; 2008 Nov 02; 38(11):849-56. PubMed ID: 19021703
    [Abstract] [Full Text] [Related]

  • 18. Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin.
    Devineni D, Morrow L, Hompesch M, Skee D, Vandebosch A, Murphy J, Ways K, Schwartz S.
    Diabetes Obes Metab; 2012 Jun 02; 14(6):539-45. PubMed ID: 22226086
    [Abstract] [Full Text] [Related]

  • 19. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
    Guerrero-Romero F, Rodríguez-Morán M.
    Eur J Clin Invest; 2006 Nov 02; 36(11):796-802. PubMed ID: 17032347
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA.
    Clin Ther; 2006 Jan 02; 28(1):55-72. PubMed ID: 16490580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.